Literature DB >> 17054678

Guidelines on the management of acute myeloid leukaemia in adults.

D W Milligan, D Grimwade, J O Cullis, L Bond, D Swirsky, C Craddock, J Kell, J Homewood, K Campbell, S McGinley, K Wheatley, G Jackson.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17054678     DOI: 10.1111/j.1365-2141.2006.06314.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  35 in total

1.  Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

Authors:  Vikas Gupta; Martin S Tallman; Wensheng He; Brent R Logan; Edward Copelan; Robert Peter Gale; Hanna J Khoury; Thomas Klumpp; John Koreth; Hillard M Lazarus; David I Marks; Rodrigo Martino; David A Rizzieri; Jacob M Rowe; Mitchell Sabloff; Edmund K Waller; John F DiPersio; Donald W Bunjes; Daniel J Weisdorf
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation.

Authors:  Martin David Berger; Bernhard Gerber; Kornelius Arn; Oliver Senn; Urs Schanz; Georg Stussi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

3.  Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.

Authors:  John F DiPersio; Harry P Erba; Richard A Larson; Selina M Luger; Martin S Tallman; Jeffrey M Brill; Gregoire Vuagniaux; Elisabeth Rouits; J Mel Sorensen; Claudio Zanna
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-03-05

4.  The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).

Authors:  Bruno C Medeiros; Megan Othus; Martin S Tallman; Zhuoxin Sun; Hugo F Fernandez; Jacob M Rowe; Hillard M Lazarus; Frederick R Appelbaum; Selina M Luger; Mark R Litzow; Harry P Erba
Journal:  Leuk Res       Date:  2019-01-17       Impact factor: 3.156

5.  Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data.

Authors:  Sherlly Xie; Md Jobayer Hossain
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

Review 6.  Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.

Authors:  Irina A Tikhonova; Martin W Hoyle; Tristan M Snowsill; Chris Cooper; Joanna L Varley-Campbell; Claudius E Rudin; Ruben E Mujica Mota
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

Review 7.  Decitabine: a review of its use in older patients with acute myeloid leukaemia.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

8.  New considerations in the design of clinical trials for the treatment of acute leukemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Clin Investig (Lond)       Date:  2011-04-01

Review 9.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

Authors:  Margaret L Gulley; Thomas C Shea; Yuri Fedoriw
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

10.  New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.

Authors:  Huiyang Li; Cha Han; Ke Li; Jie Li; Yingmei Wang; Fengxia Xue
Journal:  Cancer Biol Ther       Date:  2018-11-19       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.